Biome Australia (ASX:BIO) EBIT: A$1.17 Mil (TTM As of Dec. 2025)


ASX:BIO Biome Australia Ltd ASX:BIO
35 GF Score
Price A$0.25
GF Value A$0.70
Valuation Possible Value Trap
! 5 Warning Signs
View Full Analysis

What is Biome Australia EBIT?

Biome Australia ASX:BIO 35 EBIT is A$1.17 Mil as of Dec. 2025. GuruFocus rates ASX:BIO with a GF Score™ of 35/100 and a GF Value™ of A$0.70 (Possible Value Trap). The stock has 5 warning signs investors should review.

Biome Australia's earnings before interest and taxes (EBIT) for the six months ended in Dec. 2025 was A$1.29 Mil. Its earnings before interest and taxes (EBIT) for the trailing twelve months (TTM) ended in Dec. 2025 was A$1.17 Mil.

EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition. Biome Australia's annualized ROC % for the quarter that ended in Dec. 2025 was 21.66%. Biome Australia's annualized ROC (Joel Greenblatt) % for the quarter that ended in Dec. 2025 was 52.32%.

EBIT is also linked to Joel Greenblatt's definition of earnings yield. Biome Australia's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Dec. 2025 was 2.13%.

Biome Australia  (ASX:BIO) EBIT Explanation

1. EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.

Biome Australia's annualized ROC % for the quarter that ended in Dec. 2025 is calculated as:

ROC % (Q: Dec. 2025 )
=NOPAT/Average Invested Capital
=Operating Income * ( 1 - Tax Rate % )/( (Invested Capital (Q: Jun. 2025 ) + Invested Capital (Q: Dec. 2025 ))/ count )
=1.266 * ( 1 - 0% )/( (5.622 + 6.07)/ 2 )
=1.266/5.846
=21.66 %

where

Invested Capital(Q: Jun. 2025 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=11.968 - 3.6 - ( 2.746 - max(0, 7.18 - 11.441+2.746))
=5.622

Invested Capital(Q: Dec. 2025 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=12.309 - 2.883 - ( 3.356 - max(0, 5.493 - 10.989+3.356))
=6.07

Note: The Operating Income data used here is two times the semi-annual (Dec. 2025) data.

2. Joel Greenblatt's definition of Return on Capital:

Biome Australia's annualized ROC (Joel Greenblatt) % for the quarter that ended in Dec. 2025 is calculated as:

ROC (Joel Greenblatt) %(Q: Dec. 2025 )
=EBIT/Average of (Net fixed Assets + Net Working Capital)
=EBIT/Average of (Property, Plant and Equipment+Net Working Capital)
     Q: Jun. 2025  Q: Dec. 2025
=EBIT/( ( (Property, Plant and Equipment + Net Working Capital) + (Property, Plant and Equipment + Net Working Capital) )/ count )
=2.578/( ( (0.363 + max(4.537, 0)) + (1.079 + max(3.876, 0)) )/ 2 )
=2.578/( ( 4.9 + 4.955 )/ 2 )
=2.578/4.9275
=52.32 %

where Working Capital is:

Working Capital(Q: Jun. 2025 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(4.328 + 4.112 + 0.255) - (3.6 + 0 + 0.558)
=4.537

Working Capital(Q: Dec. 2025 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(3.311 + 3.892 + 0.43) - (2.883 + 0 + 0.874)
=3.876

When net working capital is negative, 0 is used.

Note: The EBIT data used here is two times the semi-annual (Dec. 2025) EBIT data.

3. It is also linked to Joel Greenblatt's definition of Earnings Yield:

Biome Australia's Earnings Yield (Joel Greenblatt) % for today is calculated as:

Earnings Yield (Joel Greenblatt) %=EBIT (TTM)/Enterprise Value (Q: Dec. 2025 )
=1.17/54.935
=2.13 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Biome Australia EBIT Related Terms

Biome Australia EBIT Historical Data

* Premium members only.

The historical data trend for Biome Australia's EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Biome Australia EBIT Chart

Biome Australia Annual Data
Trend Jun21 Jun22 Jun23 Jun24 Jun25
EBIT
0.00 -4.51 -2.99 -1.52 0.40

Biome Australia Semi-Annual Data
Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
EBIT Get a 7-Day Free Trial Premium Member Only Premium Member Only -1.46 -0.07 0.52 -0.12 1.29

ASX:BIO vs KHC, GIS: EBIT Comparison

For the Packaged Foods subindustry, Biome Australia's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Biome Australia EV-to-EBIT vs Consumer Packaged Goods Industry

For the Consumer Packaged Goods industry and Consumer Defensive sector, Biome Australia's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Biome Australia's EV-to-EBIT falls into.


ASX:BIO
35GF Score
Biome Australia Ltd ASX:BIO
EBIT is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Biome Australia EBIT Calculation

EBIT, sometimes also called Earnings Before Interest and Taxes, is a measure of a firm's profit that includes all expenses except interest and income tax expenses. It is the difference between operating revenues and operating expenses. When a firm does not have non-operating income, then Operating Income is sometimes used as a synonym for EBIT and operating profit.

EBIT for the trailing twelve months (TTM) ended in Dec. 2025 adds up the semi-annually data reported by the company within the most recent 12 months, which was A$1.17 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EBIT →
What does a EBIT of A$1.17 Mil mean?
Biome Australia (ASX:BIO) has a EBIT of A$1.17 Mil as of Dec. 2025. Earnings before interest and taxes is the difference between operating revenue and operating expenses. View historical data on Biome Australia.
Is Biome Australia's EBIT too high?
Biome Australia's current EBIT is A$1.17 Mil. Overall, Biome Australia has a GF Score™ of 35/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Biome Australia's EBIT compare to KHC and GIS?
Biome Australia's EBIT of A$1.17 Mil can be compared against companies in the Consumer Packaged Goods industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBIT for a Consumer Packaged Goods company?
A good EBIT depends on the Consumer Packaged Goods industry context. However, EBIT should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBIT mean?
A high EBIT can signal that a stock is expensive relative to its fundamentals. Earnings before interest and taxes is the difference between operating revenue and operating expenses. View historical data on Biome Australia. Biome Australia's current EBIT is A$1.17 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Biome Australia stock overvalued right now?
Based on GuruFocus' analysis, Biome Australia (ASX:BIO) is currently considered Possible Value Trap. The stock's GF Value™ is A$0.70, compared to a current price of A$0.25 — trading 65% below its estimated fair value. The current EBIT is A$1.17 Mil. Biome Australia's overall GF Score™ is 35/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBIT calculated?
EBIT is calculated from a company's financial statements. For Biome Australia (ASX:BIO), the current EBIT is A$1.17 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Biome Australia (ASX:BIO) Overvalued in 2026?

Based on GuruFocus' analysis, Biome Australia stock appears to be undervalued. The current stock price of A$0.25 is trading 65% below its estimated GF Value™ of A$0.70. GuruFocus considers Biome Australia to be Possible Value Trap.

Key valuation signals for ASX:BIO:

  • EBIT: A$1.17 Mil
  • GF Value™: A$0.70 vs. price of A$0.25 (65% below fair value)
  • GF Score™: 35/100 with 5 warning signs

No single metric tells the full story. See the ASX:BIO stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Biome Australia Business Description

Address 192-194 Johnston Street, Collingwood, VIC, AUS, 3066
Biome Australia Ltd licences, develops, and markets evidence-based, complementary medicines, including nutraceuticals vitamins and weight management products and live biotherapeutics. The company has one operating segment: researching, developing, manufacturing and distributing evidence-based products linking the gut and human health. Domestically it caters to Australia and In international markets, the Group distributes and markets its Activated Probiotics range in the United Kingdom and New Zealand through independent health practitioners.
35GF Score

Get the complete analysis for ASX:BIO

EBIT is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

A$0.25
Price
A$0.70
GF Value